Diagnostic Ultrasound - Abdomen and Pelvis
Ovarian Metastases Including Krukenberg Tumor TERMINOLOGY Definitions • Secondary (metastatic) neoplasms to ovary • Krukenberg tumor ○ Subtype of metastatic tumors that contain > 10% mucinfilled signet cells in cellular stroma ○ Usually from gastrointestinal tract, with 76% arising from stomach ○ Krukenberg tumor is sometimes used inappropriately by some to include all metastatic ovarian carcinomas • High-stage mucinous tumors involving ovary frequently represent metastases from extraovarian primary sites and are often misdiagnosed as primary ovarian mucinous tumors IMAGING General Features • Best diagnostic clue ○ Bilateral ovarian masses in patients with known primary carcinoma ○ Metastases to ovary are usually solid masses – However, cystic and necrotic areas can be seen and tumors may resemble primary ovarian cancer • Location ○ Usually bilateral ○ Majority of metastases from colon are bilateral (80%) – If unilateral, more common in right ovary • Size ○ Often large masses • Morphology ○ Lobulated masses with smooth external contour – 92% of ovarian metastases from colon cancer show smooth margin compared with 45% of primary ovarian cancers ○ Nonspecific imaging features in isolation Ultrasonographic Findings • Grayscale ultrasound ○ Ovarian mass ○ Solid or cystic and solid – Rarely unilocular cyst – May be complicated by hemorrhage – May mimic mucinous cystadenocarcinoma with multiple locules • Color Doppler ○ Solid components demonstrate variable vascularity CT Findings • NECT ○ Metastatic ovarian tumors often have soft tissue density but may demonstrate low-attenuation cystic or necrotic areas • CECT ○ Solid components often demonstrate heterogeneous enhancement ○ Cystic and necrotic areas do not enhance ○ Metastatic colorectal carcinoma may appear as multilocular cystic lesion with stained-glass appearance – Loculi with variable attenuation – Mimics primary mucinous ovarian cancer MR Findings • T1WI ○ Solid components demonstrate intermediate signal intensity • T2WI ○ Solid components demonstrate heterogeneous signal intensity ○ Cystic and necrotic components demonstrate high signal intensity ○ Loculi within multilocular tumors may show variable signal intensities • T1WI C+ ○ Solid components show marked heterogeneous enhancement Nuclear Medicine Findings • PET ○ PET/CT is modality of choice for tumor staging and shows variable increased metabolic uptake in ovarian metastases Imaging Recommendations • Best imaging tool ○ Ultrasound is usually 1st modality to demonstrate ovarian involvement in patient with known malignancy ○ CT and MR can be used to assess extent of disease DIFFERENTIAL DIAGNOSIS Primary Ovarian Cancer • Most primary ovarian carcinomas are predominantly cystic masses ○ Multilocularity of cystic mass suggests primary ovarian tumor • Most secondary malignancies of ovary are predominantly solid or mixture of solid and cystic areas Ovarian Lymphoma • Ovarian lymphomas are often homogeneous solid masses • Extensive involvement of lymph node chains is seen in lymphoma PATHOLOGY General Features • Etiology ○ Metastases to ovary occur by hematogenous, lymphatic, transperitoneal, or direct extension ○ Primary sites of nongynecologic tumors – Colon (30%) □ Metastatic colon cancers to ovary usually arise from distal lesions, most commonly rectosigmoid, followed in decreasing order by transverse colon, ascending colon, cecum, and descending colon – Stomach (16%), appendix (13%), breast (13%), pancreas (12%), biliary tract (15%), and liver (4%) ○ Common gynecologic primary sites – Uterine body (23%), uterine cervix (4%) Staging, Grading, & Classification • Staging is based on staging system of primary malignancy Diagnoses: Female Pelvis 861
Ovarian Metastases Including Krukenberg Tumor Diagnoses: Female Pelvis Gross Pathologic & Surgical Features • Cut surfaces of ovaries may be solid, solid-cystic, or multicystic • Have tendency to preserve contour of ovary • Hemorrhage or necrosis may be present within mass Microscopic Features • Hyperplasia of ovarian stromal cells with significant number of signet ring cells • Features favoring metastatic rather than primary ovarian neoplasm include ○ Bilaterality ○ Nodular pattern of ovarian involvement ○ Infiltrative pattern of stromal invasion ○ Microscopic surface deposits of tumor ○ Marked lymphovascular invasion (especially in hilum and outside ovary) ○ Signet ring cells ○ Cells floating in mucin ○ Variation in growth pattern from 1 nodule to another • Due to high risk of ovarian metastasis, palliative bilateral oophorectomy may be performed during surgery for colon cancer DIAGNOSTIC CHECKLIST Consider • Imaging findings of primary ovarian cancer and metastases to ovaries overlap in many cases, and confident imaging distinction between the 2 may be challenging • In patients with metastases to ovaries, primary tumor is often clinically overt and associated with findings of widespread metastatic disease • Investigation of gastrointestinal tract is recommended in patient without known primary cancer Image Interpretation Pearls • Features that are more often seen in metastases to ovary include ○ Bilateral ovarian masses ○ Predominantly solid appearance of mass CLINICAL ISSUES Presentation • Most common signs/symptoms ○ Abdominal pain ○ Palpable pelvic masses • Other signs/symptoms ○ Occasionally associated hormonal activity can be seen due to reactive ovarian stromal hyperplasia • Clinical profile ○ In many cases, there is known history of primary neoplasm ○ Usually symptoms of primary disease precede symptoms secondary to ovarian metastasis ○ On occasion, presentation is with symptoms related to ovarian mass in patient with no known history of malignancy Demographics • Age ○ More common in premenopausal women due to vascularity of ovaries • Epidemiology ○ 5-15% of malignant ovarian tumors are metastatic tumors to ovary ○ 5-30% of cancer patients have ovarian metastases at autopsy ○ Only 30-40% of ovarian metastases are true Krukenberg tumors Natural History & Prognosis • Poor prognosis with mortality rate of ~ 90% 1 year after ovarian metastasis is discovered • Krukenburg tumors: Mean survival 23 months ○ Premenopausal patients and metachronous lesions fair better Treatment • Radical tumor-reductive surgery • Often have poor response to chemotherapy SELECTED REFERENCES 1. Jeung YJ et al: Krukenberg tumors of gastric origin versus colorectal origin. Obstet Gynecol Sci. 58(1):32-9, 2015 2. Nakamura Y et al: A Krukenberg Tumor from an Occult Intramucosal Gastric Carcinoma Identified during an Autopsy. Case Rep Oncol Med. 2014:797429, 2014 3. Alvarado-Cabrero I et al: Metastatic ovarian tumors: a clinicopathologic study of 150 cases. Anal Quant Cytol Histol. 35(5):241-8, 2013 4. La Fianza A et al: Intralesional hemorrhage in Krukenberg tumor: a case report and review of the literature. J Ultrasound. 16(2):89-91, 2013 5. Guerriero S et al: Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor. Ultrasound Obstet Gynecol. 39(5):581-6, 2012 6. Ho L et al: Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT. Clin Nucl Med. 37(5):524-7, 2012 7. Willmott F et al: Radiological manifestations of metastasis to the ovary. J Clin Pathol. 65(7):585-90, 2012 8. Kitajima K et al: FDG PET/CT features of ovarian metastasis. Clin Radiol. 66(3):264-8, 2011 9. Maeda-Taniguchi M et al: Metastatic mucinous adenocarcinoma of the ovary is characterized by advanced patient age, small tumor size, and elevated serum CA125. Gynecol Obstet Invest. 72(3):196-202, 2011 10. de Waal YR et al: Secondary ovarian malignancies: frequency, origin, and characteristics. Int J Gynecol Cancer. 19(7):1160-5, 2009 11. Koyama T et al: Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging. 32(6):784-95, 2007 12. Testa AC et al: Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor. Ultrasound Obstet Gynecol. 29(5):505-11, 2007 13. Chang WC et al: CT and MRI of adnexal masses in patients with primary nonovarian malignancy. AJR Am J Roentgenol. 186(4):1039-45, 2006 14. Khunamornpong S et al: Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality. Gynecol Oncol. 101(1):152-7, 2006 15. Kiyokawa T et al: Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol. 30(3):277-99, 2006 16. Alcazar JL et al: Transvaginal gray scale and color Doppler sonography in primary ovarian cancer and metastatic tumors to the ovary. J Ultrasound Med. 22(3):243-7, 2003 17. Jung SE et al: CT and MR imaging of ovarian tumors with emphasis on differential diagnosis. Radiographics. 22(6):1305-25, 2002 18. Brown DL et al: Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study. Radiology. 219(1):213-8, 2001 19. Hann LE et al: Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation. Radiology. 216(1):242-7, 2000 862
- Page 832 and 833: Ovarian Hyperstimulation Syndrome (
- Page 834 and 835: Serous Ovarian Cystadenoma/Carcinom
- Page 836 and 837: Serous Ovarian Cystadenoma/Carcinom
- Page 838 and 839: Mucinous Ovarian Cystadenoma/Carcin
- Page 840 and 841: Mucinous Ovarian Cystadenoma/Carcin
- Page 842 and 843: Ovarian Teratoma TERMINOLOGY Synony
- Page 844 and 845: Ovarian Teratoma (Left) Ultrasound
- Page 846 and 847: Polycystic Ovarian Syndrome TERMINO
- Page 848 and 849: Endometrioma TERMINOLOGY Synonyms
- Page 850 and 851: Endometrioma (Left) Longitudinal en
- Page 852 and 853: Hydrosalpinx TERMINOLOGY Definition
- Page 854 and 855: Hydrosalpinx (Left) Longitudinal tr
- Page 856 and 857: Tubo-Ovarian Abscess TERMINOLOGY De
- Page 858 and 859: Tubo-Ovarian Abscess (Left) Longitu
- Page 860 and 861: Parovarian Cyst TERMINOLOGY Abbrevi
- Page 862 and 863: Peritoneal Inclusion Cyst TERMINOLO
- Page 864 and 865: Peritoneal Inclusion Cyst (Left) Sa
- Page 866 and 867: Bartholin Cyst TERMINOLOGY Definiti
- Page 868 and 869: Gartner Duct Cyst TERMINOLOGY Abbre
- Page 870 and 871: Gartner Duct Cyst (Left) Longitudin
- Page 872 and 873: Sex Cord-Stromal Tumor TERMINOLOGY
- Page 874 and 875: Sex Cord-Stromal Tumor (Left) Trans
- Page 876 and 877: Sex Cord-Stromal Tumor (Left) Sagit
- Page 878 and 879: Adnexal/Ovarian Torsion TERMINOLOGY
- Page 880 and 881: Adnexal/Ovarian Torsion (Left) Long
- Page 884 and 885: Ovarian Metastases Including Kruken
- Page 886 and 887: PART III SECTION 1 Liver Hepatomega
- Page 888 and 889: Hepatomegaly - Firm consistency (du
- Page 890 and 891: Hepatomegaly Lymphoma Lymphoma (Lef
- Page 892 and 893: Diffuse Liver Disease Acute/Chronic
- Page 894 and 895: Cystic Liver Lesion ○ May be soli
- Page 896 and 897: Cystic Liver Lesion Peribiliary Cys
- Page 898 and 899: Hypoechoic Liver Mass - Adjacent he
- Page 900 and 901: Hypoechoic Liver Mass Infected Bilo
- Page 902 and 903: Echogenic Liver Mass • Fibrolamel
- Page 904 and 905: Echogenic Liver Mass Hepatic Ligame
- Page 906 and 907: Target Lesions in Liver Hepatic Met
- Page 908 and 909: Multiple Hepatic Masses ○ Cluster
- Page 910 and 911: Multiple Hepatic Masses Cirrhosis W
- Page 912 and 913: Hepatic Mass With Central Scar Foca
- Page 914 and 915: Periportal Lesion Helpful Clues for
- Page 916 and 917: Periportal Lesion Peribiliary Cyst
- Page 918 and 919: Irregular Hepatic Surface Subcapsul
- Page 920 and 921: Portal Vein Abnormality Bland Porta
- Page 922 and 923: PART III SECTION 2 Biliary System
- Page 924 and 925: Diffuse Gallbladder Wall Thickening
- Page 926 and 927: Diffuse Gallbladder Wall Thickening
- Page 928 and 929: Hyperechoic Gallbladder Wall Porcel
- Page 930 and 931: Focal Gallbladder Wall Thickening/M
Ovarian Metastases Including Krukenberg Tumor<br />
Diagnoses: Female <strong>Pelvis</strong><br />
Gross Pathologic & Surgical Features<br />
• Cut surfaces of ovaries may be solid, solid-cystic, or<br />
multicystic<br />
• Have tendency to preserve contour of ovary<br />
• Hemorrhage or necrosis may be present within mass<br />
Microscopic Features<br />
• Hyperplasia of ovarian stromal cells with significant number<br />
of signet ring cells<br />
• Features favoring metastatic rather than primary ovarian<br />
neoplasm include<br />
○ Bilaterality<br />
○ Nodular pattern of ovarian involvement<br />
○ Infiltrative pattern of stromal invasion<br />
○ Microscopic surface deposits of tumor<br />
○ Marked lymphovascular invasion (especially in hilum <strong>and</strong><br />
outside ovary)<br />
○ Signet ring cells<br />
○ Cells floating in mucin<br />
○ Variation in growth pattern from 1 nodule to another<br />
• Due to high risk of ovarian metastasis, palliative bilateral<br />
oophorectomy may be performed during surgery for colon<br />
cancer<br />
DIAGNOSTIC CHECKLIST<br />
Consider<br />
• Imaging findings of primary ovarian cancer <strong>and</strong> metastases<br />
to ovaries overlap in many cases, <strong>and</strong> confident imaging<br />
distinction between the 2 may be challenging<br />
• In patients with metastases to ovaries, primary tumor is<br />
often clinically overt <strong>and</strong> associated with findings of<br />
widespread metastatic disease<br />
• Investigation of gastrointestinal tract is recommended in<br />
patient without known primary cancer<br />
Image Interpretation Pearls<br />
• Features that are more often seen in metastases to<br />
ovary include<br />
○ Bilateral ovarian masses<br />
○ Predominantly solid appearance of mass<br />
CLINICAL ISSUES<br />
Presentation<br />
• Most common signs/symptoms<br />
○ Abdominal pain<br />
○ Palpable pelvic masses<br />
• Other signs/symptoms<br />
○ Occasionally associated hormonal activity can be seen<br />
due to reactive ovarian stromal hyperplasia<br />
• Clinical profile<br />
○ In many cases, there is known history of primary<br />
neoplasm<br />
○ Usually symptoms of primary disease precede symptoms<br />
secondary to ovarian metastasis<br />
○ On occasion, presentation is with symptoms related to<br />
ovarian mass in patient with no known history of<br />
malignancy<br />
Demographics<br />
• Age<br />
○ More common in premenopausal women due to<br />
vascularity of ovaries<br />
• Epidemiology<br />
○ 5-15% of malignant ovarian tumors are metastatic<br />
tumors to ovary<br />
○ 5-30% of cancer patients have ovarian metastases at<br />
autopsy<br />
○ Only 30-40% of ovarian metastases are true Krukenberg<br />
tumors<br />
Natural History & Prognosis<br />
• Poor prognosis with mortality rate of ~ 90% 1 year after<br />
ovarian metastasis is discovered<br />
• Krukenburg tumors: Mean survival 23 months<br />
○ Premenopausal patients <strong>and</strong> metachronous lesions fair<br />
better<br />
Treatment<br />
• Radical tumor-reductive surgery<br />
• Often have poor response to chemotherapy<br />
SELECTED REFERENCES<br />
1. Jeung YJ et al: Krukenberg tumors of gastric origin versus colorectal origin.<br />
Obstet Gynecol Sci. 58(1):32-9, 2015<br />
2. Nakamura Y et al: A Krukenberg Tumor from an Occult Intramucosal Gastric<br />
Carcinoma Identified during an Autopsy. Case Rep Oncol Med. 2014:797429,<br />
2014<br />
3. Alvarado-Cabrero I et al: Metastatic ovarian tumors: a clinicopathologic study<br />
of 150 cases. Anal Quant Cytol Histol. 35(5):241-8, 2013<br />
4. La Fianza A et al: Intralesional hemorrhage in Krukenberg tumor: a case<br />
report <strong>and</strong> review of the literature. J <strong>Ultrasound</strong>. 16(2):89-91, 2013<br />
5. Guerriero S et al: Preoperative diagnosis of metastatic ovarian cancer is<br />
related to origin of primary tumor. <strong>Ultrasound</strong> Obstet Gynecol. 39(5):581-6,<br />
2012<br />
6. Ho L et al: Bilateral ovarian metastases from gastric carcinoma on FDG<br />
PET/CT. Clin Nucl Med. 37(5):524-7, 2012<br />
7. Willmott F et al: Radiological manifestations of metastasis to the ovary. J Clin<br />
Pathol. 65(7):585-90, 2012<br />
8. Kitajima K et al: FDG PET/CT features of ovarian metastasis. Clin Radiol.<br />
66(3):264-8, 2011<br />
9. Maeda-Taniguchi M et al: Metastatic mucinous adenocarcinoma of the ovary<br />
is characterized by advanced patient age, small tumor size, <strong>and</strong> elevated<br />
serum CA125. Gynecol Obstet Invest. 72(3):196-202, 2011<br />
10. de Waal YR et al: Secondary ovarian malignancies: frequency, origin, <strong>and</strong><br />
characteristics. Int J Gynecol Cancer. 19(7):1160-5, 2009<br />
11. Koyama T et al: Secondary ovarian tumors: spectrum of CT <strong>and</strong> MR features<br />
with pathologic correlation. Abdom Imaging. 32(6):784-95, 2007<br />
12. Testa AC et al: Imaging in gynecological disease (1): ultrasound features of<br />
metastases in the ovaries differ depending on the origin of the primary<br />
tumor. <strong>Ultrasound</strong> Obstet Gynecol. 29(5):505-11, 2007<br />
13. Chang WC et al: CT <strong>and</strong> MRI of adnexal masses in patients with primary<br />
nonovarian malignancy. AJR Am J Roentgenol. 186(4):1039-45, 2006<br />
14. Khunamornpong S et al: Primary <strong>and</strong> metastatic mucinous adenocarcinomas<br />
of the ovary: Evaluation of the diagnostic approach using tumor size <strong>and</strong><br />
laterality. Gynecol Oncol. 101(1):152-7, 2006<br />
15. Kiyokawa T et al: Krukenberg tumors of the ovary: a clinicopathologic<br />
analysis of 120 cases with emphasis on their variable pathologic<br />
manifestations. Am J Surg Pathol. 30(3):277-99, 2006<br />
16. Alcazar JL et al: Transvaginal gray scale <strong>and</strong> color Doppler sonography in<br />
primary ovarian cancer <strong>and</strong> metastatic tumors to the ovary. J <strong>Ultrasound</strong><br />
Med. 22(3):243-7, 2003<br />
17. Jung SE et al: CT <strong>and</strong> MR imaging of ovarian tumors with emphasis on<br />
differential diagnosis. Radiographics. 22(6):1305-25, 2002<br />
18. Brown DL et al: Primary versus secondary ovarian malignancy: imaging<br />
findings of adnexal masses in the Radiology <strong>Diagnostic</strong> Oncology Group<br />
Study. Radiology. 219(1):213-8, 2001<br />
19. Hann LE et al: Adnexal masses in women with breast cancer: US findings with<br />
clinical <strong>and</strong> histopathologic correlation. Radiology. 216(1):242-7, 2000<br />
862